Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mohamed A. Atassi, MD, is a regional cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute. He practices at the Cleveland Clinic Willoughby Family Health Center. He is board certified in internal medicine and cardiovascular disease.
Dr. Atassi earned his medical degree from the University of Damascus, Syria. His post-doctoral training included an internship at Christ Hospital, Jersey City, NJ, followed by residencies at Coney Island City Hospital and Maimonidis Hospital, Coney Island Division, both in Brooklyn, NY. After completing a six-month fellowship in cardiology at Cleveland Clinic, he returned to Syria where he was director of cardiology, Military Hospital, Damascus, for three years and an associate professor of medicine at the University of Damascus for two years of that appointment. He returned to the United States to complete his training with an additional fellowship in cardiology at Cleveland Clinic.
Dr.Atassi was named to the Cleveland Clinic Heart& Vascular Institute regional staff in 2010. Prior to his appointment he was president and CEO of Heart Specialists, Inc., Willoughby, Ohio, a private practice in cardiology that he founded in 1975. He continued as a staff cardiologist at Lake Hospitals system until 2012, when he was moved to honorary staff where he has been on the Active medical staff since 1975.
Dr. Atassi’s professional memberships included the American Medical Association, American College of Physicians, Lake County Medical Society (past president), National Arab American Medical Association (past president), the Society of Cardiac Computed Tomography, Ohio State Medical Association and the American Heart Association, the Society of Angiography and Intervention,He is a Fellow of the American College of Cardiology and the American Society of Echocardiography.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/5/2016, Dr. Atassi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.